Related Experiment Video
Updated: May 15, 2026

Bio-energetics Investigation of Candida albicans Using Real-time Extracellular Flux Analysis
Published on: March 19, 2019
[Multi-organ failure in a patient with fungaemia due to Saprochaete capitata]
I Villa López1, A Doblas Claros, J M Saavedra
1Servicio de Cuidados Críticos y Urgencias, Hospital Juan Ramón Jiménez, Huelva, España.
Background:
The significant increase in systemic fungal infections is mainly due to the increase in immunocompromised patients. The high morbimortality of these infections, along with the high hospitalization costs they generate, makes them a problem of great importance in our hospital practice. Saprochaete capitata is a rare fungus that causes invasive infections, usually in immunocompromised patients, and for which there is still no consensus on the treatment regimen to be used.
Case Report:
We present a case of disseminated infection by this fungus in a heavily immunosuppressed patient, who died as a result of multiple organ failure despite the life support measures taken and the wide spectrum antibiotics.
Conclusions:
It is vital to begin the antibiotic treatment as soon as possible, as well as the monitoring and follow-up cultures to test for fungi in neutropenic patients.
Insights
Systemic fungal infections are rising, particularly in immunocompromised individuals. Early antifungal treatment and monitoring are crucial for managing rare fungal infections like Saprochaete capitata, especially in neutropenic patients.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Systemic fungal infections are increasing due to a rise in immunocompromised patients.
- These infections contribute to significant morbidity, mortality, and healthcare costs.
- Saprochaete capitata causes rare invasive infections with no established treatment consensus.
Observation:
- A case of disseminated Saprochaete capitata infection in a severely immunocompromised patient is presented.
- The patient experienced multiple organ failure despite life support and broad-spectrum antibiotics.
- This highlights the challenges in treating invasive fungal infections in vulnerable populations.
Findings:
- Disseminated infection by Saprochaete capitata can be fatal even with intensive medical care.
- The lack of consensus on treatment regimens poses a significant clinical challenge.
- Prompt diagnosis and intervention are critical for patient outcomes.
Implications:
- Early initiation of antifungal therapy is vital for managing invasive fungal infections.
- Regular monitoring and fungal cultures are essential for neutropenic patients.
- Further research is needed to establish effective treatment protocols for rare fungal pathogens.
Related Concept Videos
Fungal Group Zygomycota
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Antifungal Agents
Acute Respiratory Failure-III
Fungal Phylum Microsporidia
Pneumonia III: Complications and Assessment